XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating expenses        
General and administrative $ 1,405,026 $ 1,134,845 $ 3,647,224 $ 5,117,591
Research and development 2,300,277 1,158,820 6,835,700 3,888,676
Total operating expenses (3,705,303) (2,293,665) (10,482,924) (9,006,267)
Other income (expenses)        
Grant income 69,146 47,767 121,116 113,701
Research and development incentive income 2,022,902 571,093
Interest income, net 26,677 2,626 48,479 6,832
Gain on settlement of accounts payable 75,204 75,204 151,402
Financing related charges and adjustments (8) (1,175)
Foreign exchange gain (loss) (65,932) 8,924 (40,128) (37,637)
Total other income, net 105,095 59,309 2,227,573 804,216
Net loss before provision for income taxes (3,600,208) (2,234,356) (8,255,351) (8,202,051)
Income tax expense - current (9,877) (6,000) (50,480) (23,615)
Net loss and comprehensive loss $ (3,610,085) $ (2,240,356) $ (8,305,831) $ (8,225,666)
Loss per share        
Basic and diluted (in dollars per share) $ (0.09) $ (0.06) $ (0.21) $ (0.24)
Weighted average number of shares outstanding        
Basic and diluted (in shares) 41,509,225 35,709,686 40,344,149 34,961,838